Guidelines Of Marketing Plan For Flu

To get the flu vaccine or not to get the flu vaccine? This is a huge controversial question millions of Americans today ask themselves every year. There are many myths that come along with the topic of the flu vaccine that lead to people questioning the effectiveness of the medication. Safety for our families and loved ones is what we aim to achieve, but what are the pros and cons of this vaccine? What are the consequences and what are myths, but most importantly: what are the reasons we should get it in the first place? In this paper you will learn the many reasons for the flu vaccination and how it affects different populations beginning with children all the way to the elderly population. First of all, what is the flu

Influenza viruses are divided into three classes. These are A, B, and C. Influenza A and B are blamed for the increases in hospitalization and deaths each year. The aim of receiving an annual vaccine is to prevent spreading infections. Since flu outbreaks vary, it is recommended that individuals receive a vaccination for the flu

Every year, millions of people start talking about the influenza virus and getting their vaccines as the flu season approaches, which starts around the October-November period and reaches its peak between December and March. Therefore, public health officials around the world- and in the U.S in particular- are constantly challenged by properly preparing for the annual influenza dilemma, given that this viruses, and other respiratory viruses, are a serious health threat to the U.S population and the world as a whole. Furthermore, what makes the influenza virus even more challenging to control is that it can mutate rapidly and reassort to form new strains, having the ability to reside in multiple animal hosts. In fact, many scientists and researchers have been doing in-depth intensive research so as to understand the mechanism behind this unique characteristic of the virus, try to find new ways to control it, and explore different areas of protection and vaccination.

According to the Centers for Disease Control and Prevention, “It's estimated that 90 percent of seasonal flu-related deaths and more than 60 percent of seasonal flu-related hospitalizations in the United States each year occur in people 65 years and older “ (2011).The CDC advises that the best way to prevent and control the spread of influenza each year is by the use of vaccinnations. In effort to control and prevent influenza epidemics, the CDC uses the epidemiological process to predict the strain of the virus that will be most relevant to the population and this data is used to formulate influenza vaccinations (Centers for Disease Control and Prevention, 2011).

Seasonal influenza is a major cause of mortality and morbidity in the industrialized world. The United States alone averages more than 23,000 influenza-associated deaths annually (Cortes-Penfield, 2014). Everyone is given the option to receive the flu vaccination each year. The vaccine is offered in health care facilities, clinics, and pharmacies around

Each year 6-20% of U.S. residents are infected by influenza and more than 200,000 people are hospitalized due to complications (Klepser, Corn, Schmidt, Dering-Anderson, & Klepser, 2015). Influenza has a huge impact on not only the health of our nation, but economically, as well. Studies show that the single most effective way to prevent the spread of influenza is to vaccinate. The CDC recommends that all children over 6 months old to be vaccinated against influenza yearly (CDC, n.d.). Seldom have there been medical advancements that have impacted the health of billions of people. One such important medical advancement is the invention of vaccines. At the end of the 20th century, the CDC published its list of

Influenza is responsible for hospitalizations and deaths in the United States. Prevention through vaccination is one way to circumvent illnesses, hospitalizations and deaths. Those persons who were more susceptible fall into the categories of 6 months to 4 years of age and 65 years and older. According to CDC (2013), the 2012-13 influenza season was characterized as a moderately severe season based on the surveillance data. Regardless of suggestions and encouragements of schools and places of employment for individuals to be vaccinated against the flu, fewer than half the persons in the United States each year are inoculated against this disease. Influenza vaccines are now widely used to reduce the burden of annual epidemics of influenza virus infections (Cowling, et al., 2016).

There is a division in the medical community about the benefits of getting vaccinated against the flu. Some medical professionals insist that vaccination against the flu can decrease death by fifty percent, while others provide evidence against such a claim. It is difficult to determine how many people die from the flu, who has the flu, and which strain of the flu someone has. There are over 200 viruses that cause flu like systems. In reality, researchers believe that only 7 or 8 percent of cases of people actually contract the flu that report systems associated with the flu such as, headache, fever, coughing, etc. The flu can mutate very quickly causing the virus to differ every flu season if only slightly. Thus, members of the World Health

Seasonal Influenza is the monitored acquisition of the current avian influenza affecting a patient in that particular season, it commonly presents itself as a common cold but then advances to show more serious symptoms, in addition the seasonal influenza can mutate if not treated properly creating yet another strand of the attenuated virus. A primary health care physician can only diagnose seasonal influenza because some symptoms mimic those of the common cold, however the seasonal influenza is often misdiagnosed- one of the many reasons attempts of retention struggle. However there is a solution in the prevention of these epidemics and they include the proper implementation on the influenza vaccines. There are two different types of vaccines the Intramuscular injection is applied to the forearm and the LAIV (live

Last year in 2014, "the flu vaccine was ineffective against a predominant strain of flu which led to almost 18,000 people being hospitalized" (Leonard, 2015). The vaccine is only 60% effective against certain strains of the flu but scientist continue to conduct research to improve the effectiveness of the drug (Leonard, 2015). Each year there is a potential for new strains to become relevant with new people entering the country or people taking vacations. More than half of the population fail to get vaccinated even though it is readily available when flu season begins and there is proof that it can be effective. Every year researchers try to determine how well the flu vaccine works and confirm the value of the flu vaccination to public health (“Vaccine Effectiveness - How Well Does the Flu Vaccine Work?”). The CDC states that “There are two factors that play an important role in determining the likelihood the vaccine will protect a person from flu illness: characteristics such as age and health of a person and the similarity between the virus and vaccination” (“Vaccine Effectiveness - How Well Does the Flu Vaccine

Influenza remains as a significant global threat to public health. In United States alone, a typical influenza epidemic results in over 25 million infections, 300,000 hospitalizations and 13,000 deaths every year (1). The virus evolves antigenically from one year to the next, requiring annual reformulation of the vaccine and leading to variable vaccine efficacy. Exacerbating this natural antigenic evolution, adaptation to the chicken eggs may occur during the manufacture of virus used to produce the inactivated vaccine (2). This year such adaptation has reduced the vaccine efficacy against H3N2 strain (3). Low vaccine efficacy is expected to generate higher attack rates, as has already occured in Australia (3, 4). Compounding the effects of low vaccine efficacy, public perception following the widespread media attention may depress vaccine uptake for a given year. The combination of low vaccine efficacy and low coverage has the potential to reduce herd immunity, putting the population at risk of elevated infection incidence and ultimately high rates of infections and mortality. Consequently, optimizing epidemiological effectiveness of vaccination given vaccine efficacy is imperative to minimize the annual mortality and morbidity of influenza.

The United States during the 2004-2005 flu season identified many problems related to shortage of Flu vaccines. The diagram below shows the trends of flu vaccine availability from 1992-1993 till the 2008-2009 seasons in the United States. In the 2000-2001 flu season, the demand for vaccine exceeded supply due to challenges encountered from developing new viral strain and quality control issues by manufacturing industries which led

Influenza is a respiratory infection caused by a range of flu virus. The virus is very contagious and can cause mild to severe illness and even death. Droplets spread the virus, especially when infected people cough, sneeze or talk. Touching a contaminated surface or object can also transmit the virus. Getting vaccinated annually is the best method of averting the flu virus. When there is a vaccine shortage, it will be fair and ethical to give the vaccine to the most vulnerable or high-risk members of the society such as; those with asthma, diabetes, and heart diseases, children and the elderly and most importantly health care workers. Selling the vaccine will undermine those at high risk who cannot afford to buy the vaccine. The ethical principles of Utilitarian and egalitarianism are the contending principles for rationing the seasonal flu vaccine.

The Flu vaccine is a medicine developed by, epidemiologists, microbiologists, physicians and other public health experts to protect the society from three to four influenza viruses that will occur and cause disease for the following season and the data is acquired through research or forecast. The Center for Disease Control

In summary, the influenza vaccine is a strong agreement between the controls of the effective measure to reduce the spread of influenza, which is caused disease among research experts. It is a represents a few severe side effects. Experts acknowledge that there may be effective in increasing vaccination rates to be identified barriers to vaccination and immunization programs